Skip to main content
. 2023 Jun 14;7(5):100280. doi: 10.1016/j.rpth.2023.100280

Table 3.

Predictors of overall and late mortality in the whole cohort and in patients without active cancer.

Characteristic Overall mortality during follow-up (n = 361)
Late mortality after >30 d (n = 283)
Late mortality after >30 d in patients without active cancer (n = 180)
Univariable model HR (95% CI) Multivariable model HR (95% CI)a Univariable model HR (95% CI) Multivariable model HR (95% CI)a Univariable model HR (95% CI) Multivariable model HR (95% CI)a
Age per decade 1.50 (1.38-1.63) 1.45 (1.30-1.61) 1.56 (1.42-1.72) 1.49 (1.32-1.68) 2.17 (1.87-2.53) 1.97 (1.66-2.33)
Sex (female) 0.93 (0.75-1.16) - 0.91 (0.72-1.16) - 0.88 (0.65-1.19) -
Obesity (BMI >30 kg/m2) 0.77 (0.60-0.98) 0.75 (0.57-0.98) 0.69 (0.53-0.91) 0.65 (0.48-0.87) 0.68 (0.48-0.96) 0.66 (0.45-0.98)
Comorbidities
Chronic heart failure 2.13 (1.66-2.74) 1.45 (1.09-1.92) 2.30 (1.75-3.04) 1.67 (1.23-2.28) 3.57 (2.60-4.90) 1.84 (1.31-2.59)
Coronary artery disease 1.74 (1.35-2.23) 1.14 (0.86-1.50) 1.83 (1.39-2.42) 1.12 (0.82-1.52) 2.54 (1.83-3.52) 1.04 (0.73-1.48)
Prior stroke 1.95 (1.44-2.64) 1.45 (1.05-1.99) 1.85 (1.31-2.62) 1.34 (0.93-1.92) 2.38 (1.60-3.53) 1.23 (0.82-1.86)
Arterial hypertension 1.48 (1.17-1.87) 0.83 (0.64-1.08) 1.54 (1.19-1.99) 0.93 (0.70-1.24) 2.25 (1.59-3.19) 0.90 (0.61-1.32)
Chronic pulmonary disease 1.66 (1.28-2.17) 2.03 (1.54-2.68) 1.70 (1.26-2.28) 2.16 (1.58-2.93) 1.97 (1.39-2.81) 2.22 (1.51-3.27)
Active cancer 3.61 (2.88-4.53) 3.76 (2.95-4.80) 4.07 (3.17-5.23) 4.22 (3.23-5.51) - -
Diabetes mellitus 1.51 (1.16-1.96) 1.33 (1.01-1.75) 1.41 (1.05-1.90) 1.27 (0.93-1.73) 1.66 (1.17-2.37) 1.20 (0.83-1.73)
Renal insufficiency 1.99 (1.59-2.48) 1.17 (0.91-1.52) 1.97 (1.54-2.52) 1.07 (0.80-1.41) 3.35 (2.47-4.54) 1.17 (0.82-1.65)
Anemia 2.30 (1.85-2.85) 1.80 (1.43-2.25) 2.27 (1.79-2.89) 1.84 (1.44-2.36) 1.84 (1.36-2.50) 1.62 (1.19-2.21)
Prior VTE 0.76 (0.59-0.98) 0.71 (0.55-0.92) 0.84 (0.64-1.11) - 1.00 (0.72-1.39) -

Bold text indicates statistically significant results.

BMI, body mass index; HR, hazard ratio; VTE, venous thromboembolism.

a

Including all univariable predictors.